This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Romanian to English: Product Information - Section 4.3 of Summary of Product Characteristics -Contraindications General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - Romanian 4.3 Contraindicaţii
- Sindrom imunodeficitar.
- Pacienţi cu risc crescut de infecţii oportunistice, inclusiv pacienţi imunocompromişi (inclusiv
cei cărora li se administrează în prezent terapii imunosupresive sau cei imunocompromişi de
terapiile anterioare).
- Infecţii active severe, infecţii cronice active (hepatită, tuberculoză).
- Neoplazii active.
- Insuficienţă hepatică severă (Child-Pugh clasa C).
- Pacienți care în ultimele 6 luni au avut infarct miocardic (IM), angină pectorală instabilă,
accident vascular cerebral/atac ischemic tranzitor (AIT), insuficiență cardiacă decompensată
(care necesită tratament în spital) sau insuficiență cardiacă clasa III/IV New York Heart
Association (NYHA) (vezi pct. 4.4).
- Pacienți cu aritmii cardiace severe care necesită tratament antiaritmic cu medicamente
antiaritmice de clasa Ia sau III (vezi pct. 4.4).
- Pacienți cu bloc AV Mobitz II de gradul doi sau trei, sindromul sinusului bolnav sau care nu au
pacemaker (vezi pct. 4.4).
- Pacienți cu interval QTc la momentul inițial ≥500 msec (vezi pct. 4.4).
- În timpul sarcinii și la femeile cu potențial fertil care nu utilizează metode contraceptive eficace
(vezi pct. 4.4 și 4.6).
- Hipersensibilitate la substanţa activă sau la oricare dintre excipienţii enumeraţi la pct. 6.1.
Translation - English 4.3 Contraindications
- Immunodeficiency syndrome.
- Patients with increased risk for opportunistic infections, including immunocompromised
patients (including those currently receiving immunosuppressive therapies or those
immunocompromised by prior therapies).
- Severe active infections, active chronic infections (hepatitis, tuberculosis).
- Active malignancies.
- Severe liver impairment (Child-Pugh class C).
- Patients who in the previous 6 months had myocardial infarction (MI), unstable angina pectoris,
stroke/transient ischaemic attack (TIA), decompensated heart failure (requiring inpatient
treatment), or New York Heart Association (NYHA) class III/IV heart failure (see section 4.4).
- Patients with severe cardiac arrhythmias requiring anti-arrhythmic treatment with class Ia or
class III anti-arrhythmic medicinal products (see section 4.4).
- Patients with second-degree Mobitz type II atrioventricular (AV) block or third-degree AV
block, or sick-sinus syndrome, if they do not wear a pacemaker (see section 4.4).
- Patients with a baseline QTc interval ≥ 500 msec (see section 4.4).
- During pregnancy and in women of childbearing potential not using effective contraception (see
sections 4.4 and 4.6).
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
More
Less
Translation education
Master's degree - Moldova University
Experience
Years of experience: 17. Registered at ProZ.com: Mar 2020.
Keywords: Translation in my language pairs of pharmaceutical dossiers, business/official correspondence, product information for European Medicines Agency and for
European Union National Competent Authorities -following QRD templates for the CP, DCP or national templates -for Germany and France, medical device IFUs, clinical reports, patient information documents. Please send enquiries at [email protected]
Expertise